comparemela.com

Latest Breaking News On - University of florida at gainesville - Page 4 : comparemela.com

People news: Slocum-Dickson adds physician to pediatric department

NEW HARTFORD, N.Y. Slocum-Dickson Medical Group has announced the addition of physician Elaine Tsukayama to its pediatric department effective Nov. 13.

United statesLoma linda universityLoma lindaElaine tsukayamaUniversity of florida at gainesvillePacific union college in angwinAmerican academy of pediatricsLoma linda university school of medicineSlocum dickson medical groupAmerican academyPacific union collegeLoma linda university schoolNew hartford

Other Days

100 years ago

United statesWilliams baptist collegePine bluffUniversity of arkansasJefferson countyFayetteville john nimsJerol swaimDwayne meyerDoris meyerElizabeth rinchusoUniversity of florida at gainesvilleArkansas baptist state conventionCreative writing programDepartment of englishGovernor broughIron pastoral

COOLERCHIPS Project Takes On Data Center Cooling Challenge | Data Center Knowledge | News and analysis for the data center industry

Here's how the University of Florida is using its $3.2M COOLERCHIPS grant to develop an innovative way to cool chips used in data centers.

Big fourSaeed moghaddamLisa sparksUniversity of florida at gainesvilleData center knowledgeUs department of energySoftware drive data center sustainability effortsEnergy arpae cooling operations optimized for leapsLimitations of legacy cooling technologyUniversity of floridaAerospace engineeringResearch projects agencyData centerAdvanced research projects agency energyCooling operations optimizedCarbon hyperefficiency

BioCardia Announces Interim Efficacy Results in Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial

SUNNYVALE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today announced it has finalized external review of interim data and evaluated interim efficacy results for the ongoing Phase III pivotal trial of CardiAMP® Cell Therapy for Heart Failure (CardiAMP HF, clinicaltrials.gov Identifier: NCT02438306), for which the FDA granted Breakthrough Designation fo

United statesUniversity of wisconsinPeter altmanCarl pepineMiranda petoDavid mcclungStatistical data analysis centerExchange commission onUniversity of florida at gainesvilleNational principal investigatorBiocardia incNational principal investigatorsMaryland stem cell research fundCardiamp cell therapy programCell therapyHeart failure

BioCardia Announces Interim Efficacy Results in Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial - BioCardia (NASDAQ:BCDA)

SUNNYVALE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) BioCardia®, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, today

United statesUniversity of wisconsinCarl pepineDavid mcclungMiranda petoPeter altmanCardiamp cell therapy programNational principal investigatorsUniversity of florida at gainesvilleBiocardia incNational principal investigatorStatistical data analysis centerExchange commission onMaryland stem cell research fundCell therapyHeart failure

vimarsana © 2020. All Rights Reserved.